You are here

  • Home
  • Archive
  • Volume 11, Issue 12
  • ASCC3 promotes the immunosuppression and progression of non-small cell lung cancer by impairing the type I interferon response via CAND1-mediated ubiquitination inhibition of STAT3

Article metrics

Article menu

This article has a correction. Please see:

Basic tumor immunology
Original research
ASCC3 promotes the immunosuppression and progression of non-small cell lung cancer by impairing the type I interferon response via CAND1-mediated ubiquitination inhibition of STAT3

 

Online download statistics by month:

Online download statistics by month: December 2023 to March 2026

AbstractFullPdf
Dec 2023376377197
Jan 2024666670418
Feb 2024198198127
Mar 2024182185126
Apr 2024191192144
May 2024143144112
Jun 2024198198126
Jul 2024183183107
Aug 202414414396
Sep 2024168172116
Oct 2024196196121
Nov 202418418696
Dec 2024279285168
Jan 2025237237143
Feb 2025358358151
Mar 2025189189146
Apr 2025234234149
May 2025160161115
Jun 2025767650
Jul 2025110
Aug 2025110
Nov 2025001
Feb 2026001
Mar 2026001
Total436443862711